TRMKTrustmark CorporationMid cap · $2.72B · FY ending 2025-12-31
$46.39+0.26% · 2026-07-13 · EOD
58/100 composite
A transparent blend of the four reads below — each opens into the tool it comes from. Not advice.Quality—
margins & F-ScoreValue61
P/E 12.5 · 93% of 12-mo rangeMomentum64
golden · price above 200-daySmart Money50
quiet · 0 funds · 0P/0S insidersBullish stackGolden crossAbove 200-day
vs S&P 500+5.9%
6-mo excess Trailing performance1M +2.6%
3M +3.3%
6M +14.6%
YTD +18.7%
1Y +19.9%
P/E vs its last 12 months (our price history): 9.9 low → 12.7 high
Current price sits at the 93th percentile of that window — near the top (richer). We only compare against the price history we own (no paid multi-year multiples — nothing invented).
ROIC = NOPAT ÷ (debt + equity − cash), using an effective tax rate of 18%. Annual figures from SEC XBRL.
Dividend & capital return
Payout ratio26.1%
comfortable Shareholder yield5.1%
dividends + buybacks Annual figures from SEC cash-flow statements. Shareholder yield = total cash returned ÷ market cap.
Quiet0P / 0S insiders · 0 funds hold · 0 Congress buys
No recent insider, Congress, or fund activity on file for TRMK.
Bhealth · 77/100
Self-fundingSelf-funding — profitable · generates cash
- ●Active dilution shelf An effective S-3 shelf with 2 prospectus filing(s) in 12 months — shares may be getting sold into the market.
Educational tools — not financial advice. Fundamentals from SEC EDGAR (XBRL); prices are end-of-day (Databento). Scores are a transparent blend of the components shown, computed on our own data — a research aid, not a recommendation.